In a deal that could top $1 billion, Merck & Co has teamed up with US biotech Janux Therapeutics to bring T-cell immunotherapies to cancer patients. The agreement sees San Diego-based Janux in ...

If there's anything else to say t-mobile is need to go back to the $50 dollar pre pay monthly and beat the competition right out. Use are good, I'd not ever had no issue, service has been great.

At its third attempt, Mesoblast has secured FDA approval for Ryoncil as a treatment for children with graft-versus-host disease, the first-ever approval for a mesenchymal stromal cell (MSC ...

9983.T Fast Retailing Co., Ltd.

Apr. 16, 2025 — Scientists have discovered how aging blood stem cells acquire mutations that give them a growth edge, creating fertile ground for the development of clonol hematopoiesis ...